These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35401325)

  • 21. Diversity of returnee executives' foreign experience and corporate social responsibility performance.
    Wu Y; Zhang W; Li H
    PLoS One; 2024; 19(4):e0300262. PubMed ID: 38557680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does institutional quality complement the relationship between ownership structure and corporate social responsibility?
    Ali S; Zhang R; Talha M; Ali Z
    Heliyon; 2024 Jun; 10(11):e31994. PubMed ID: 38882305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do political incentives promote or inhibit corporate social responsibility? The role of local officials' tenure.
    Wu Y
    PLoS One; 2023; 18(3):e0283183. PubMed ID: 36930614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investor attention and corporate social responsibility of family businesses in Vietnam: The moderating role of CEO overpower.
    Duong KD; Nguyen HTH; Truong PH; Le HTP
    PLoS One; 2024; 19(7):e0306989. PubMed ID: 39028704
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CEO Overconfidence, Corporate Governance, and R&D Smoothing in Technology-Based Entrepreneurial Firms.
    Huang Y; Wang X; Li Y; Yu X
    Front Psychol; 2022; 13():944117. PubMed ID: 35910989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corporate social responsibility, internal control, and firm financial performance.
    Zhang L; Su W
    Front Psychol; 2022; 13():977996. PubMed ID: 36660285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Board interlocks and Corporate Social Responsibility data in the Mexican Stock Exchange.
    Briseño-García A
    Data Brief; 2022 Jun; 42():108231. PubMed ID: 35599815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Relationship between Corporate Social Responsibility and Firm Value of Chinese Firms: Exploring from Degree of Internationalization.
    Wu R; Hossain MA; Teng Z; Shen X
    J Environ Public Health; 2023; 2023():7249799. PubMed ID: 36747500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden or Blessing? CEO Early-Life Adversity Experience and Firm Internationalization Performance.
    Zhou P; Zhao Y; Zhao K
    Front Psychol; 2022; 13():855316. PubMed ID: 35592170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Moderating role of financial ratios in corporate social responsibility disclosure and firm value.
    Naseem MA; Lin J; Rehman RU; Ahmad MI; Ali R
    PLoS One; 2019; 14(4):e0215430. PubMed ID: 30998740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How does analyst coverage influence corporate social responsibility (CSR)? The governance- and information-based perspectives.
    Liu Y; Du X
    PLoS One; 2024; 19(4):e0302165. PubMed ID: 38683785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Demonstrating the Impact of Cognitive CEO on Firms' Performance and CSR Activity.
    Li H; Hang Y; Shah SGM; Akram A; Ozturk I
    Front Psychol; 2020; 11():278. PubMed ID: 32184747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CEO Regulatory Focus, Analysts' Optimism Bias, and Firm Strategic Change: Evidence From Chinese-Listed Companies.
    Huang C; Zheng W
    Front Psychol; 2022; 13():813920. PubMed ID: 35401381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does Whipping Tournament Incentives Spur CSR Performance? An Empirical Evidence From Chinese Sub-national Institutional Contingencies.
    Khan MK; Ali S; Zahid RMA; Huo C; Nazir MS
    Front Psychol; 2022; 13():841163. PubMed ID: 35282226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chairman Narcissism and Social Responsibility Choices: The Moderating Role of Analyst Coverage.
    Gao Q; Gao L; Long D; Wang Y
    Behav Sci (Basel); 2023 Mar; 13(3):. PubMed ID: 36975270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CEO successor origins, top management team faultline, and strategic change-empirical evidence from China.
    Ren D; Jiang H; Cheng J; Peng C; Zou Y
    Heliyon; 2023 Sep; 9(9):e19200. PubMed ID: 37662732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CEO Overconfidence and Corporate Innovation Outcomes: Evidence From China.
    Li Z; Zhang Y
    Front Psychol; 2022; 13():760102. PubMed ID: 35197895
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elucidating the effectiveness of cognitive CEO on corporate environmental performance: the mediating role of corporate innovation.
    Sarfraz M; He B; Shah SGM
    Environ Sci Pollut Res Int; 2020 Dec; 27(36):45938-45948. PubMed ID: 32808125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of CEO tenure on corporate social and environmental performance: an emerging country's analysis.
    Khan TM; Gang B; Fareed Z; Yasmeen R
    Environ Sci Pollut Res Int; 2020 Jun; 27(16):19314-19326. PubMed ID: 32212078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of CEO Narcissism and Corporate R&D Investment.
    Wang L; Li H; Mu Y
    Front Psychol; 2022; 13():888618. PubMed ID: 35645881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.